Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

gatric cancer

- PMLiVE

Pricing pressures preventing UK access to MenB vaccine

GlaxoSmithKline’s Bexsero will need a dramatic price cut to gain NHS entry

- PMLiVE

FDA panel backs GSK’s asthma drug Breo for adults only

Already approved to treat COPD in the US

- PMLiVE

GSK: We had a social responsibility to work on Ebola

And company says it delayed more commercialprojects to do so

- PMLiVE

GSK and Lilly invest in $100m global Dementia Discovery Fund

Fund announced at WHO conference by UK health secretary Jeremy Hunt

- PMLiVE

GSK sells another chunk of South Africa’s Aspen

Paid $418m for an 18% share in Aspen in 2009

Choices, choices: the rapidly evolving HIV treatment landscape

The treatment options for HIV in Europe has seen some revolutionary changes

- PMLiVE

GSK fires Chinese staff over corruption charges

110 employees reportedly dismissed for misconduct

- PMLiVE

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year

Ex Sanofi boss joins Boston start-up

Chris Viehbacher joins other industry veterans as the newest board member of PureTech

- PMLiVE

Novartis and GSK complete oncology and vaccines swap

Follows Swiss company's decision to divest its BRAF and MEK inhibitors to Array BioPharma

- PMLiVE

GSK replaces head of US operations

Deidre Connelly to be replaced by Jack Bailey

- PMLiVE

GSK buys vaccine specialist GlycoVaxyn for $190m

Acquisition will expand GSK’s early vaccines pipeline

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links